Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies

Author(s): Saiju Jacob, Yusuf A. Rajabally

Journal Name: Current Neuropharmacology

Volume 7 , Issue 4 , 2009

Become EABM
Become Reviewer
Call for Editor


Intravenous immunoglobulins (IVIg) have been shown in a number of trials, to be an effective treatment for the three main types of inflammatory neuropathies: Guillain-Barre Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). IVIg is thought to exert its immunomodulatory effects by affecting several components of the immune system including B-cells, T-cells, macrophages, complement, cytokines and cellular adhesion molecules. This article reviews the published evidence and the principal postulated mechanisms of action of intravenous immunoglobulins with special emphasis on inflammatory neuropathies.

Keywords: Intravenous immunoglobulins, mechanisms of action, inflammatory neuropathy, Guillain Barre syndrome, Chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [337 - 342]
Pages: 6
DOI: 10.2174/157015909790031166
Price: $65

Article Metrics

PDF: 4